Skip to main content
U.S. Edition
Thursday, July 29, 2021

Novavax COVID-19 vaccine

Vaccine candidate against COVID-19


Novavax COVID-19 vaccine
Novavax COVID-19 vaccine

The Novavax COVID-19 vaccine, codenamed NVX-CoV2373, is a COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), that is undergoing trials in India under the brand name Covovax. It requires two doses and is stable at 2 to 8 °C refrigerated temperatures.

0 shares 2 views

News coverage